Servais A, Janssen MCH, Blakey H, Greco M, Lemoine S, Martin-Moreno PL, Game D, Levtchenko E, Lipkin G
Interestingly, the intermediate dose of 12.0 mg/kg/day was associated with diminished cardiac function, suggesting a nuanced relationship between Sema dosage and cardiac health that warrants further exploration to understand the underlying mechanisms fully
After 24 weeks, patients taking the highest dose 12 milligrams lost, on average, 17.5% of their body weight, the equivalent of, on average, 41 pounds, according to the company
Strong Shelf Appeal
With proper medical supervision and regular follow-up visits, semaglutide GLP-1 therapy can provide sustained appetite regulation